Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
52.00
+0.30 (0.58%)
Aug 15, 2025, 5:30 PM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 637.94 million as of August 15, 2025. Its market cap has increased by 34.13% in one year.

Market Cap
637.94M
Enterprise Value
628.90M
Revenue
208.54M
Ranking
n/a
PE Ratio
8.93
Stock Price
52.00

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 637.94M, an increase of 19.62%. That is a compound annual growth rate of 0.84%.

History

DateMarket Cap% Change
Aug 15, 2025637.94M27.28%
Dec 30, 2024501.21M18.52%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 211.51B
Novartis AG 186.29B
Lonza Group AG 38.57B
Alcon 34.30B
Galderma Group AG 31.34B
Sandoz Group AG 20.62B
Straumann Holding AG 16.52B
Sonova Holding AG 13.47B
Market Cap Rankings